09:56 AM EDT, 04/22/2024 (MT Newswires) -- Guardant Health ( GH ) said Monday that a panel of the US Food and Drug Administration Medical Devices Advisory Committee will review the premarket approval application for its Shield blood test for colorectal cancer screening on May 23.
Shares of the company rose 7.7% in recent trading.